Long-Range PCR and Long-Read Sequencing for Carrier Screening Research

The AmplideX® Nanopore Carrier Plus Kit (RUO) from Asuragen is a flexible genetic analysis solution for carrier screening research, designed to interrogate 11 genes associated with increased at-risk couple rates. Its modular design uses four assay mixes across the 11 genes, allowing laboratories to select any combination of targets to suit their testing requirements.

Featuring a single, streamlined workflow, the AmplideX® Nanopore Carrier Plus can consolidate existing assays and methods, serving as either a primary genetic analysis approach or a complement to existing next-generation sequencing (NGS) workflows for large gene panels.

By combining long-range PCR with long-read sequencing, the kit provides additional genetic insights and can reduce the need for reflex testing compared with traditional methods. AmplideX® One Reporter software further simplifies data analysis and reporting, supporting an efficient, streamlined carrier screening research workflow.

 

Watch: The AmplideX Nanopore Carrier Plus Kit: A Long-Range PCR & Long-Read Sequencing Solution for Carrier Screening Research

 

Features and benefits

  • Consolidated workflow. Single, flexible workflow designed to consolidate existing assays and methods.
  • Greater insight. The use of long-read sequencing provides additional insight compared to existing methods (e.g. AGG interruptions in FMR1), reducing the need for reflex testing.
  • Integrated data analysis. The AmplideX® One Reporter software further simplifies data analysis and reporting with customised visuals for each variant type to assist genotype interpretation.
  • The design utilises four mixes across the 11 genes with modularity to allow any combination of testing.

 

Kit Configuration

Figure 1. The kit covers eleven genes across four mixes.

One Workflow, 9 High-Prevalence Carrier Screening Conditions, 11 Genes

 

Figure 2. High level assay workflow for the AmplideX® Nanopore Carrier Plus Kit.

 

Explore the streamlined workflow of the Carrier Plus Kit in Asuragen’s interactive experience:

 

 

Figure 3. Hands-on time and instrument time for AmplideX® Nanopore Carrier Plus Kit (24 samples run across Mix A, B, C)

 

Analytical Performance & Visual Outputs

Examples of visual outputs for various genes/mixes 

Figure 4. Pre-Mutation (PM) sample with no AGG on PM allele (20(11AGG), 70 CGG). FMR1 output provides CGG sizing and AGG phase and location for each allele.

 

Sample NA10797 – compound HET FIL/SEA sample

 

 

Figure 5. HBA1/2 fold change plot provides accurate copy number and identification of major deletion genotypes

 

Sample NA14733 – 2 copies of CYP21A2 with one of the two copies being a CH-5 fusion

Figure 6. Resolution of CYP21A2/TNXB gene/pseudogene structure down to each exon provides clear visualisation of the various changes in this region including phased SNVs.

 

Streamlining carrier screening insights, even for the most challenging genes

Combine long-range PCR and long-read sequencing to gain deeper genetic insights across 11 key genes, with a flexible carrier screening research workflow designed to simplify testing and reduce the need for reflex analysis.

Interested in bringing long-read sequencing into your carrier screening research? Contact VH Bio by filling in the form below to find out more about the AmplideX® Nanopore Carrier Plus Kit and how it could support your laboratory’s genetic analysis workflows.

 

Further resources

Performance Evaluation of a PCR/Nanopore Assay for Carrier Screening for Cystic Fibrosis, Spinal Muscular Atrophy, and Fragile X Syndrome

Scientific Posters

A Nanopore Sequencing Assay for Comprehensive Molecular Characterization of Hemoglobinopathy-Associated Variants

A Comprehensive and Streamlined Approach to Deciphering Challenging ACMG Tier 3 Carrier Screening Genes

Feasibility of PromethION Platform Expansion with the AmplideX® Nanopore Carrier Plus Kit for High Throughput Applications

Verification of an Integrated Amplification-Based Nanopore Sequencing Assay and Automated Software Solution to Genotype Challenging, Clinically-Relevant Variants | Presented at ESHG 2025

Two-Site Comparison of a Single PCR Enrichment and Nanopore Sequencing Workflow for Complex Clinically-Relevant Variants in Seven Genes Associated with Hereditary Diseases | Presented at ESHG 2025

Evaluation of the AmplideX® SMA Plus Kit for Comprehensive End-to-End SMN1/SMN2 Analysis in Spinal Muscular Atrophy | Presented at ESHG 2025

Verification of an Amplification Based Nanopore Sequencing Assay and Software to Genotype Complex, Clinically-Relevant Variants in 11 Hard-to-Decipher Genes with High Carrier Frequencies

Resolving Complex Genotypes in Residual Clinical Samples with Long Range-PCR and Nanopore Sequencing Assay

AMP 2024: Beta evaluation of AmplideX PCR enrichment technology with Nanopore long-read DNA sequencing of a panel of eleven challenging genes

Videos

Breaking Barriers in Carrier Screening and Beyond: Unlocking Complex Variants with AmplideX® Enrichment and Long-Read Sequencing

Long-Range PCR Meets Long-Read Sequencing: An Assay for 11 Hard-to-Decipher, High-Frequency Carrier Screening Associated Genes

Oxford Nanopore: Advancing Human Genetics & Cancer Research

Achieving Success with the AmplideX Nanopore Carrier Plus Kit: One Lab’s Experience

A Glimpse into AmplideX Nanopore Carrier Plus Kit in a Lab Setting

Enquire about this product

"*" indicates required fields